![](/img/cover-not-exists.png)
Efficacy and Safety of a New Prolonged Release Formulation of Alfuzosin 10 mg Once Daily versus Alfuzosin 2.5 mg Thrice Daily and Placebo in Patients with Symptomatic Benign Prostatic Hyperplasia
van Kerrebroeck, P., Jardin, A., Laval, K.U., van Cangh, P.Volume:
37
Year:
2000
Language:
english
Journal:
European Urology
DOI:
10.1159/000052361
File:
PDF, 135 KB
english, 2000